Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
ImmunoGen, Inc.,IMGN151-1001
Scientific Title
A Phase 1, First-in-Human, Open-Label, Dose-Escalation and Expansion Study of IMGN151 (Anti-FRα Antibody-drug Conjugate) in Adult Patients With Recurrent Endometrial Cancer and Recurrent, High-Grade Serous Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers